EDAP vs. SMTI, SNWV, ZIMV, TCMD, NYXH, NVRO, DRTS, SKIN, CATX, and BWAY
Should you be buying Edap Tms stock or one of its competitors? The main competitors of Edap Tms include Sanara MedTech (SMTI), SANUWAVE Health (SNWV), ZimVie (ZIMV), Tactile Systems Technology (TCMD), Nyxoah (NYXH), Nevro (NVRO), Alpha Tau Medical (DRTS), Beauty Health (SKIN), Perspective Therapeutics (CATX), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry.
Edap Tms vs.
Edap Tms (NASDAQ:EDAP) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations.
Sanara MedTech has higher revenue and earnings than Edap Tms. Sanara MedTech is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.
Sanara MedTech has a net margin of -10.71% compared to Edap Tms' net margin of -34.92%. Sanara MedTech's return on equity of -19.86% beat Edap Tms' return on equity.
62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by company insiders. Comparatively, 54.1% of Sanara MedTech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Edap Tms presently has a consensus target price of $8.50, indicating a potential upside of 388.34%. Sanara MedTech has a consensus target price of $49.50, indicating a potential upside of 60.82%. Given Edap Tms' higher possible upside, analysts clearly believe Edap Tms is more favorable than Sanara MedTech.
Edap Tms received 325 more outperform votes than Sanara MedTech when rated by MarketBeat users. However, 61.54% of users gave Sanara MedTech an outperform vote while only 60.38% of users gave Edap Tms an outperform vote.
In the previous week, Edap Tms had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 3 mentions for Edap Tms and 1 mentions for Sanara MedTech. Edap Tms' average media sentiment score of 1.13 beat Sanara MedTech's score of 0.64 indicating that Edap Tms is being referred to more favorably in the media.
Edap Tms has a beta of 0.13, suggesting that its share price is 87% less volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500.
Summary
Sanara MedTech beats Edap Tms on 11 of the 18 factors compared between the two stocks.
Get Edap Tms News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Edap Tms Competitors List
Related Companies and Tools
This page (NASDAQ:EDAP) was last updated on 5/28/2025 by MarketBeat.com Staff
